Richard Schilsky to Drugs, Investigational
This is a "connection" page, showing publications Richard Schilsky has written about Drugs, Investigational.
Connection Strength
0.237
-
Determining If a Somatic Tumor Mutation Is Targetable and Options for Accessing Targeted Therapies. J Oncol Pract. 2019 11; 15(11):575-583.
Score: 0.172
-
An investigational new drug treatment program for patients with gemcitabine: results for over 3000 patients with pancreatic carcinoma. Cancer. 1999 Mar 15; 85(6):1261-8.
Score: 0.042
-
WIN Consortium--challenges and advances. Nat Rev Clin Oncol. 2011 Mar; 8(3):133-4.
Score: 0.024